Crewe Advisors »

Seelos Therapeutics Inc Class Equity shares owned by Crewe Advisors

Quarter-by-quarter ownership of Seelos Therapeutics Inc Class Equity shares owned by Crewe Advisors from 13F filings

Historical chart of Crewe Advisors investment in Seelos Therapeutics Inc Class Equity

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Inc Class Equity held by Crewe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Inc Class Equity by Crewe Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $69 115 0.60

More positions owned by Crewe Advisors

Ensign (ENSG)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard World Esg Us Stk Etf (ESGV)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Vanguard World Esg Intl Stk Etf (VSGX)
Vanguard Index Fds Small Cp Etf (VB)
Microsoft Corporation (MSFT)
Chevron Corporation (CVX)
Pennant Group (PNTG)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Crewe Advisors

Top funds holding Seelos Therapeutics Inc Class Equity

AdvisorShares Investments
Morgan Stanley
Geode Capital Management
BlackRock
Tower Research Capital
Jpmorgan Chase & Co
Bank of America Corporation
Group One Trading
Vermillion & White Wealth Management Group
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group
Westside Investment Management
National Bank Of Canada /fi/
Pnc Financial Services

View all funds holding Seelos Therapeutics Inc Class Equity